Compendium of Cancer Genome Aberrations

Changes

EYE5:Volunteer Assignments and Opportunities (view source)

Revision as of 16:13, 26 January 2024

16,157 bytes added ,  16:13, 26 January 2024
no edit summary
Line 18: Line 18:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|- |Usual ductal hyperplasia||Disease||
+
|-
 +
|CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Epithelial_conjunctival_inclusion_cyst|Epithelial conjunctival inclusion cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Reactive_epithelial_hyperplasia_of_the_conjunctiva|Reactive epithelial hyperplasia of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Papillary_and_follicular_conjunctivitis|Papillary and follicular conjunctivitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pterygium_and_pingueculum|Pterygium and pingueculum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epibulbar_choristoma_(dermoid;_dermolipoma;_complex_choristoma)|Epibulbar choristoma (dermoid; dermolipoma; complex choristoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_cell_papilloma|Conjunctival squamous cell papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_oncocytoma|Conjunctival oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Hereditary_benign_intraepithelial_dyskeratosis|Hereditary benign intraepithelial dyskeratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_intraepithelial_neoplasia|Conjunctival squamous intraepithelial neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_cell_carcinoma|Conjunctival squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adenosquamous_carcinoma|Adenosquamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Benign_epithelial_melanosis_of_the_conjunctiva|Benign epithelial melanosis of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Junctional,_compound_and_subepithelial_conjunctival_naevi|Junctional, compound and subepithelial conjunctival naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Blue_naevus_of_the_conjunctiva|Blue naevus of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Combined_naevus|Combined naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_melanoma|Conjunctival melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 3 (TUMOURS OF THE EYELID)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Epidermal_inclusion_cyst|Epidermal inclusion cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Intratarsal_cyst_|Intratarsal cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Phakomatous_choristoma|Phakomatous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Molluscum_contagiosum|Molluscum contagiosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Verruca_vulgaris|Verruca vulgaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Squamous_cell_papilloma|Squamous cell papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Seborrheic_keratosis|Seborrheic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Inverted_follicular_keratosis|Inverted follicular keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Actinic_keratosis|Actinic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Basal_cell_carcinoma|Basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ductal_hidrocystoma|Ductal hidrocystoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Sebaceous_hyperplasia,_adenoma,_and_sebaceoma|Sebaceous hyperplasia, adenoma, and sebaceoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Syringoma|Syringoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mixed_tumour|Mixed tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Tubular_adenoma|Tubular adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Trichilemmoma|Trichilemmoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Sebaceous_carcinoma|Sebaceous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mucinous_carcinoma|Mucinous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Apocrine_carcinoma|Apocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Naevi_of_the_eyelid|Naevi of the eyelid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:In-situ_cutaneous_melanoma|In-situ cutaneous melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Invasive_cutaneous_melanoma|Invasive cutaneous melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 4 (TUMOURS OF THE UVEAL TRACT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Ectopic_tissue|Ectopic tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Implantation_cyst|Implantation cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pigmented_epithelial_cyst|Pigmented epithelial cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lisch_nodule|Lisch nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ocular_melanocytosis|Ocular melanocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Iris_naevus|Iris naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Iris_melanoma|Iris melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Choroidal_and_ciliary_body_naevi|Choroidal and ciliary body naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Uveal_melanocytoma|Uveal melanocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Bilateral_diffuse_uveal_melanocytic_proliferation|Bilateral diffuse uveal melanocytic proliferation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Choroidal_and_ciliary_body_melanomas|Choroidal and ciliary body melanomas]]
 +
|Disease
 +
|
 +
|
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Astrocytic_tumours|Astrocytic tumours]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 792:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Nodular_and_massive_retinal_gliosis|Nodular and massive retinal gliosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 803:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Retinocytoma|Retinocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 814:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Retinoblastoma|Retinoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 825:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Hamartoma_of_the_retinal_pigment_epithelium|Hamartoma of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 836:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Congenital_hypertrophy_of_the_retinal_pigment_epithelium|Congenital hypertrophy of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 847:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Reactive_hyperplasia_of_the_retinal_pigment_epithelium|Reactive hyperplasia of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 858:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Adenoma_and_adenocarcinoma_of_the_retinal_pigment_epithelium|Adenoma and adenocarcinoma of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 869:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Reactive_epithelial_hyperplasia_of_the_ciliary_epithelium|Reactive epithelial hyperplasia of the ciliary epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 880:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Nodular_hyperplasia_of_the_ciliary_epithelium|Nodular hyperplasia of the ciliary epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 891:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Glioneuronal_hamartoma_of_the_ciliary_body|Glioneuronal hamartoma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 902:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Adenoma_and_adenocarcinoma_of_the_ciliary_body|Adenoma and adenocarcinoma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 913:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Medulloepithelioma_of_the_ciliary_body|Medulloepithelioma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 924:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Optic_nerve_choristoma|Optic nerve choristoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 955:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Gliomas_of_the_optic_nerve|Gliomas of the optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 966:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Medulloepithelioma_of_the_optic_disc_and_optic_nerve|Medulloepithelioma of the optic disc and optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 977:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Meningioma_of_the_optic_nerve|Meningioma of the optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 988:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Melanocytoma_of_the_optic_disc_and_optic_nerve|Melanocytoma of the optic disc and optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 999:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Dacryops_cyst|Dacryops cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 1,030:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Pleomorphic_adenoma_of_the_lacrimal_gland|Pleomorphic adenoma of the lacrimal gland]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 1,041:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Lacrimal_gland_oncocytoma|Lacrimal gland oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 1,052:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Myoepithelioma|Myoepithelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 1,063:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Intraductal_carcinoma|Intraductal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 1,074:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 1,085:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 1,096:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Primary_ductal_adenocarcinoma_of_the_lacrimal_gland|Primary ductal adenocarcinoma of the lacrimal gland]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 1,107:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 1,118:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 1,129:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 1,140:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 1,151:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Adenocarcinoma,_NOS|Adenocarcinoma, NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 1,162:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Papillomas_(squamous_and_inverted)|Papillomas (squamous and inverted)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 1,193:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,204:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 1,215:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 1,226:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Other_salivary_gland-type_carcinomas_of_the_lacrimal_drainage_system|Other salivary gland-type carcinomas of the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,237:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Adenocarcinoma_NOS_of_the_lacrimal_drainage_system|Adenocarcinoma NOS of the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 1,248:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Melanoma_involving_the_lacrimal_drainage_system|Melanoma involving the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 1,259:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 9 (TUMOURS OF THE ORBIT)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Orbital_dermoid_cysts_and_other_orbital_cysts|Orbital dermoid cysts and other orbital cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 1,290:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Cavernous_vascular_malformation|Cavernous vascular malformation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,301:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Combined_lymphatic-venous_malformation_of_the_orbit|Combined lymphatic-venous malformation of the orbit]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,312:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Orbital_venous_malformation_|Orbital venous malformation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,323:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Arteriovenous_malformation|Arteriovenous malformation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 1,334:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Orbital_glial_heterotopia|Orbital glial heterotopia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 1,345:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Mesenchymal_hamartoma_of_the_orbit|Mesenchymal hamartoma of the orbit]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 1,356:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Teratoma|Teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,367:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Yolk_sac_tumour|Yolk sac tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,378:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Primary_orbital_melanoma|Primary orbital melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,389:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,420:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,431:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Primary_choroidal_lymphoma|Primary choroidal lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,442:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Primary_vitreoretinal_large_B-cell_lymphoma|Primary vitreoretinal large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,453:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Extranodal_marginal_zone_lymphoma_|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,464:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,475:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,486:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,497:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,508:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,519:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:CD30_positive_lymphoproliferative_disorders|CD30 positive lymphoproliferative disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,530:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:T-cell_lymphomas|T-cell lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,541:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Extranodal_lymphoma_of_mature_NK_or_T-cell_lineage|Extranodal lymphoma of mature NK or T-cell lineage]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,552:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,563:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,574:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,585:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,596:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Langerhans_cell_tumours|Langerhans cell tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Xanthelasma|Xanthelasma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adult_orbital_xanthogranulomatous_disease|Adult orbital xanthogranulomatous disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Conjunctival_stromal_tumour_and_ocular_surface_fibroma|Conjunctival stromal tumour and ocular surface fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Fibrous_histiocytoma|Fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Nodular_and_proliferative_fasciitis,_proliferative_myositis|Nodular and proliferative fasciitis, proliferative myositis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Angiomyxoma|Angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Benign_lipomatous_tumours|Benign lipomatous tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Malignant_adipocytic_tumours|Malignant adipocytic tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Rhabdomyosarcoma_family|Rhabdomyosarcoma family]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,759:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,770:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Mesectodermal_leiomyoma|Mesectodermal leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,781:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,792:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,803:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,814:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,825:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,836:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,847:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Masson_tumour|Masson tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,858:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[EYE5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 747: Line 1,869:  
|
 
|
 
|-
 
|-
 +
|[[EYE5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lymphangiectasia|Lymphangiectasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Soft_tissue_chondroma|Soft tissue chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Metastases_to_ocular_adnexal_structures|Metastases to ocular adnexal structures]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Metastases_to_intra-ocular_structures|Metastases to intra-ocular structures]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (GENETIC TUMOUR SYNDROMES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Von_Hippel_Lindau_syndrome|Von Hippel Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Sturge_Weber_syndrome|Sturge Weber syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Goldenhar_syndrome|Goldenhar syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Muir-Torre_syndrome|Muir-Torre syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14030...14127"